We harvest the power of whole-genome and MultiOmics data through proprietary AI solutions for
therapy response predictions and drug target identiﬁcation
CDx DEVELOPMENT PIPELINE
Portfolio of predictive and prognostic models ready for licensing.
We invite investors and biopharma companies to collaborative partnerships in CDx development.
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Compound heterozygous GLI3 variants in siblings with thyroid hemiagenesis
The First Report of Biallelic Missense Mutations in the SFRP4 Gene Causing Pyle Disease in Two Siblings
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
Co-founder and CEO